Herbas VPB

Print
EN | LT
LT - Paklitakselio ir albumino nanodalelės derinyje su bevacizumabu, skirtame panaudoti prieš vėžį
EN - NANOPARTICLES OF PACLITAXEL AND ALBUMIN IN COMBINATION WITH BEVACIZUMAB AGAINST CANCER

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/337 (2006.01)
A61K 39/395 (2006.01)
A61K 45/06 (2006.01)
A61P 35/04 (2006.01)
A61P 35/00 (2006.01)
A61K 9/00 (2006.01)
A61K 9/51 (2006.01)
A61K 31/282 (2006.01)
A61K 31/7072 (2006.01)
A61K 33/24 (2006.01)
European patent
(11) Number of the document 2097078
(13) Kind of document T
(96) European patent application number 07839976.3
Date of filing the European patent application 2007-11-06
(97) Date of publication of the European application 2009-09-09
(45) Date of publication and mention of the grant of the patent 2014-04-16
(46) Date of publication of the claims translation 2014-08-25
PCT application
(86) Number PCT/US2007/023446
Date 2007-11-06
PCT application publication
(87) Number WO 2008/057562
Date 2008-05-15
Priority applications
(30) Number Date Country code
594417 2006-11-06 US
Inventors
(72)
DESAI, Neil P., US
SOON-SHIONG, Patrick, US
Grantee
(73) Abraxis BioScience, LLC, 11755 Wilshire Boulevard Suite 2100, Los Angeles, CA 90025, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Paklitakselio ir albumino nanodalelės derinyje su bevacizumabu, skirtame panaudoti prieš vėžį
  NANOPARTICLES OF PACLITAXEL AND ALBUMIN IN COMBINATION WITH BEVACIZUMAB AGAINST CANCER
Last renewal fee
Payment date Validity (years) Amount
2025-10-03 19 347.00 EUR
Next renewal fee
2026-11-06